Skip to main content
AMRX logo
AMRX
(NASDAQ)
Amneal Pharmaceuticals, Inc.
$17.91-- (--)
Loading... - Market loading

Amneal Pharmaceuticals (AMRX) Stock Price & Financial Analysis

Amneal Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$17.77 - $18.12
52-Week High$19.26
52-Week Low$9.20
Open$17.99
Volume1.36M
Average Volume (3M)1.86M
Market Cap5.88B
Shares Outstanding328.10M
P/E Ratio (TTM)38.35
Forward P/E19.09
Price to Sales (P/S)1.94
Price to Book (P/B)51.66
EV/EBITDA13.68
Revenue (TTM)3.12B
Net Income (TTM)157.60M
Free Cash Flow (TTM)73.71M
EPS (TTM)$0.48
Profit Margin5.06%
Operating Margin14.38%
Return on Equity (ROE)134.73%
Debt to Equity22.78
50-Day MA$17.21
200-Day MA$13.92
52-Week Change94.92%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Amneal Pharmaceuticals

What is the current stock price for AMRX?

As of the latest trading session, AMRX stock trades at $17.91. The 52-week range is $9.20–$19.26, with a day range of $17.77–$18.12.

What is the P/E ratio for AMRX?

Amneal Pharmaceuticals's trailing P/E ratio is 38.4, meaning investors pay $38.4 for every $1 of annual earnings. The forward P/E is 19.1, reflecting analyst expectations for future earnings. Amneal Pharmaceuticals operates in the Healthcare sector.

Does AMRX pay dividends?

Amneal Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AMRX?

Based on 4 analysts, the consensus for AMRX is Buy.

What is the market cap of AMRX?

Amneal Pharmaceuticals's market capitalization is $5.88B, classifying it as a mid-cap company. Amneal Pharmaceuticals operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.